Trends of drug shortages in China from 2018 to 2020: A retrospective observational study
Drug shortages are a major public health threat worldwide [1–3], frequently leading to suboptimal treatment, increased medical costs, and increased risks of death for patients, particularly in developing countries with limited medical sources [4–7]. It was estimated that 38% of medical errors and an additional USD 359 million per year were directly related to drug […]
Authors
- Lin Bai (ORCID: https://orcid.org/0000-0001-8892-8249)
- Huangqianyu Li (ORCID: https://orcid.org/0000-0001-8744-0276)
- Luwen Shi (ORCID: https://orcid.org/0000-0003-2683-6685)
- Tao Huang (ORCID: https://orcid.org/0000-0002-0328-1368)
- Xiaodong Guan (ORCID: https://orcid.org/0000-0002-1290-3827)
- Zhiyuan Wang (ORCID: https://orcid.org/0000-0002-1966-2421)
- Hao Li
Institutions
- Peking University (CN)
Publication Details
- Journal
- Journal of Global Health
- Published
- 2024-10-10
- DOI
- https://doi.org/10.7189/jogh.14.04225
- Citations
- 2
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 2.26